Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
marked increased » marked increase (Expand Search), marked increases (Expand Search), marked decrease (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
marked increased » marked increase (Expand Search), marked increases (Expand Search), marked decrease (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
-
1
-
2
-
3
-
4
HFD decreases intermediate-term memory.
Published 2025“…(C) Food intake was not significantly different between ND- and HFD-fed flies during the 1 hour. …”
-
5
-
6
HFD decreases ITM and alters metabolic homeostasis.
Published 2025“…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”
-
7
-
8
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
9
-
10
-
11
-
12
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025Subjects: -
13
-
14
-
15
-
16
ABT199 inhibits ALK <sup>mutant</sup> kinase activity and decreases it phosphorylation.
Published 2025Subjects: -
17
Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count.
Published 2025“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”
-
18
ATGL-1 levels increase and lipid droplets decrease in response to <i>N. parisii</i> infection.
Published 2025Subjects: -
19
-
20
Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i>
Published 2025“…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”